Dose Escalated Radiotherapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials
Abstract
BACKGROUND
Limited evidence is available on the utility of dose-escalated radiation therapy (DE-RT) +/- (TMZ) vs. standard-of-care RT (SoC-RT) for patients with newly diagnosed glioblastoma multiforme (GBM). We performed a systematic review/meta-analysis to compare overall survival (OS) and progression-free survival (PFS) between DE-RT and SoC-RT.
METHODS
We utilized a PICOS/PRISMA/MOOSE selection criterion to identify studies. The primary and secondary outcomes were 1-year OS and 1-year PFS, respectively. Outcomes and comparisons were subdivided based on receipt of TMZ and MGMT status. DE-RT was defined based on equivalent dose (EQD2) calculations. Random effects meta-analyses using the Knapp-Hartung correction, arcsine transformation, and restricted maximum likelihood method were conducted. Meta-regression was used to compare therapeutic (e.g. DE-RT and/or TMZ) and pathologic characteristics (e.g. MGMT methylation status) using the Wald-type test RESULTS: Across 22 published studies, 2,198 patients with GBM were included; 507 received DE-RT. One-year OS following DE-RT alone was higher than SoC-RT alone (46.3% vs. 23.4%; p=0.02) as was 1-year PFS (17.9% vs. 5.3%; p=0.02). No significant difference in 1-year OS (73.2% vs. 64.4%; p=0.23) or 1-year PFS (44.5% vs. 44.3%; p=0.33) between DE-RT+TMZ and SoC-RT+TMZ was noted. No difference in 1-year OS was noted between DE-RT+TMZ and SoC-RT+TMZ in either MGMT methylated (83.2% vs. 73.2%; p=0.23) or MGMT unmethylated (72.6% vs.…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,198 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.